ACM
UTHR icon

Americafirst Capital Management’s United Therapeutics UTHR Stock Holding History

Americafirst Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,610
Closed -$1.76M – 266
2016
Q2 		$1.76M Buy
16,610
+3,563
+27% +$397K 1.14% 33
2016
Q1 		$1.45M Sell
13,047
-4,082
-24% -$517K 0.91% 45
2015
Q4 		$2.68M Buy
17,129
+2,224
+15% +$324K 1.63% 16
2015
Q3 		$1.96M Sell
14,905
-2,422
-14% -$388K 1.15% 19
2015
Q2 		$3.01M Buy
17,327
+1,601
+10% +$288K 1.62% 2
2015
Q1 		$2.71M Buy
15,726
+11,654
+286% +$1.78M 1.35% 8
2014
Q4 		$527K Buy
+4,072
New +$525K 0.26% 148

Other funds holding UTHR

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Americafirst Capital Management's UTHR Position: Q3 2016 in Review

Americafirst Capital Management sold out of United Therapeutics (UTHR) in Q3 2016, closing a stake of 16,610 shares — an estimated $1.76M sold.

Americafirst Capital Management first reported a position in UTHR in Q4 2014 and held it in 7 quarters. The position peaked at $3.01M in Q2 2015. 395 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Americafirst Capital Management reported no remaining United Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Americafirst Capital Management sold 16,610 United Therapeutics shares in Q3 2016, an estimated $1.76M.
  • Americafirst Capital Management first reported a position in United Therapeutics in Q4 2014 and held it in 7 quarters.
  • Americafirst Capital Management's United Therapeutics position peaked at $3.01M in Q2 2015.
  • 395 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Americafirst Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.